Swedencare’s ProDen PlaqueOff® Dental Bites has been approved by the VOHC for scientifically proven results of plaque and tartar control and is granted the right to use the VOHC-seal

Two clinical studies* on dogs performed by DVM PhD Jerzy Gawor (President of Federation of European Companion Animal Veterinary Associations, President Elect of the European Veterinary Dental College among other positions) have shown that the product ProDen PlaqueOff® Dental Bites significantly reduce the formation of plaque and tartar. The results of the studies were the base for an application submitted to VOHC for seeking the health claim seal “helps control plaque and tartar”. Swedencare is proud to communicate that the product has been approved for the seal.
“These are the first studies we have made where ProDen PlaqueOff is included in another format than powder. We were convinced of the efficacy of the product and are pleased to have a proper and formal study showing these excellent results. The VOHC seal is also very important to us as several major veterinary players, mainly in the U.S. but also in other parts of the world, only offer products with the VOHC-seal concerning dental health. As a result, we can now with the VOHC approved product, enter a new untapped part of the market for our Dental Bites!”
– Håkan Lagerberg, CEO of Swedencare AB
*The studies were done on two groups of dogs, one group with small dogs and one with small and medium size dogs. Both groups of dogs were divided into two subgroups, one that received ProDen PlaqueOff® Dental Bites and one that received a placebo with identical composition except that it did not contain the active ingredient, the alga, Ascophyllum nodosum.
Before entering the study, all dogs were controlled to be healthy and their teeth were cleaned to remove any tartar and plaque. The dogs were given the product for 30 days and after this, the presence of plaque and tartar was measured. In both groups receiving ProDen PlaqueOff® Dental Bites, there was significant less plaque and tartar. The mean reduction in plaque index was 40% and the mean reduction in tartar was 38% after using the active product for one month compared to the placebo group. The full (90 day) studies will be formally published at a later stage.
For more information, please contact:
Jessica Hargreaves
Jessica.hargreaves@swedencare.co.uk

Share this:

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *